Skip to main content
Log in

Pneumococcal vaccine not cost effective at 65 years in Sweden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2020 euros

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pneumococcal vaccine not cost effective at 65 years in Sweden. PharmacoEcon Outcomes News 856, 24 (2020). https://doi.org/10.1007/s40274-020-6924-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6924-0

Navigation